Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Dietary Supplementation With EVOO Phenolics Prevents MCI Progression to Alzheimer's Disease
Authors not listed
Augusta University · 2026
Abstract
The goal of this clinical trial is to determine whether the extra-virgin olive oil (EVOO) phenolic dietary supplement can improve memory function and modulate biomarkers among individuals with mild cognitive impairment (MCI). The main questions it aims to answer are:
* Does dietary supplementation with EVOO phenolics improve cognitive function?
* What would be the effect of the EVOO dietary supplement on other MCI-related biomarkers, including vascular function and biological pathways?
Researchers will compare the EVOO dietary supplements with a placebo (a look-alike substance that contains no EVOO phenolics)
Participants will:
* Take EVOO dietary supplements or a placebo daily for 6 months
* Visit the study site during the 6-month study for screening and testing.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Anonymous. (2026). Dietary Supplementation With EVOO Phenolics Prevents MCI Progression to Alzheimer's Disease. <em>Augusta University</em>. https://clinicaltrials.gov/study/NCT07741773
Vancouver
Anonymous. Dietary Supplementation With EVOO Phenolics Prevents MCI Progression to Alzheimer's Disease. Augusta University. 2026.
BibTeX
@misc{anon2026Dietar,
title = {Dietary Supplementation With EVOO Phenolics Prevents MCI Progression to Alzheimer's Disease},
author = {Anonymous},
journal = {Augusta University},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Technical University of Munich 2024
Open access · US-GOV
Effect Of Daily Taurine Supplementation For 6 Months On Biological Age and Metabolic Biomarkers As Well As Physical Fitness In 55-75-year-old Women And Men: A Randomized Controlled Intervention Study
Douglas Boreham 2021
Open access · US-GOV
Clinical Trial to Assess Tolerability and Availability of a Multi-target Dietary Supplement in an Aging Population
Zhejiang Hospital 2025
Open access · US-GOV
A Prospective, Double-blind, Randomized Controlled Clinical Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients With Alzheimer's Disease
Yanbu Ke 2025
Open access · US-GOV
A Prospective, Double-blind, Randomized Controlled Clinical Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients with Alzheimer's Disease
Helse Stavanger HF 2023
Open access · US-GOV
Tolerability and Effects of a New Omega-3 Fatty Acid-based Supplement on Clinical and Biological Markers of Healthy Ageing
Universidad de Almeria 2026
Open access · US-GOV